Actionable Lessons from Vaccine Manufacturer Expansion

This white paper discusses the recent trends and challenges in the vaccine manufacturing landscape, particularly focusing on the expansion of low-cost developing country vaccine manufacturers (DCVMs) in low- and middle-income countries (LMICs). It outlines how the entrance of these manufacturers has contributed to significant reductions in vaccine prices and improvements in supply security over the past two decades. The paper also highlights the impact of Gavi, the Vaccine Alliance, in financing vaccine doses and supporting market diversification. Key profitability challenges for new Startup DCVMs are identified, including market saturation, logistical costs, and limited access to experienced labor. Additionally, the paper presents five strategic recommendations for these manufacturers to navigate the competitive landscape effectively. The document emphasizes the importance of balancing product selection and scaling operations while ensuring access to global markets. It concludes by addressing the potential risks associated with market fragmentation and the implications for vaccine affordability and health security.